Clinical Trials for Avenzo Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Avenzo Therapeutics

Clinical Trials (4)

NCT07193511
Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
PHASE1/PHASE2Recruiting
355 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2030
4 conditions1 sponsor1 location
NCT06998407
Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
PHASE1/PHASE2Recruiting
380 participants
Started: Aug 20, 2025 · Completed: Aug 31, 2030
6 conditions1 sponsor8 locations
NCT07038343
Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
PHASE1/PHASE2Recruiting
430 participants
Started: Jun 4, 2025 · Completed: Dec 31, 2030
5 conditions1 sponsor8 locations
NCT05867251
Study of AVZO-021 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
430 participants
Started: Aug 30, 2023 · Completed: Jan 31, 2030
9 conditions1 sponsor11 locations